Cargando…
Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany – results from the German AFNET registry
BACKGROUND: Anticoagulation using vitamin K antagonists (VKAs) significantly reduces the risk of recurrent stroke in stroke patients with atrial fibrillation (AF) and is recommended by guidelines. METHODS: The German Competence NETwork on Atrial Fibrillation established a nationwide prospective regi...
Autores principales: | Haeusler, Karl Georg, Gerth, Andrea, Limbourg, Tobias, Tebbe, Ulrich, Oeff, Michael, Wegscheider, Karl, Treszl, András, Ravens, Ursula, Meinertz, Thomas, Kirchhof, Paulus, Breithardt, Günter, Steinbeck, Gerhard, Nabauer, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524411/ https://www.ncbi.nlm.nih.gov/pubmed/26242880 http://dx.doi.org/10.1186/s12883-015-0371-8 |
Ejemplares similares
-
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management
por: Nabauer, Michael, et al.
Publicado: (2009) -
A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study
por: Reinecke, Holger, et al.
Publicado: (2022) -
Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial( )
por: Eckardt, Lars, et al.
Publicado: (2022) -
Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
por: Reinecke, Holger, et al.
Publicado: (2018) -
Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial
por: Willems, Stephan, et al.
Publicado: (2021)